instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'BASILIXIMAB'? | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | INDUCTION THERAPY | DrugDosageText | CC BY-NC-ND | 34695070 | 20,192,442 | 2021-10-25 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | ON DAYS 1 AND 8, EVERY 3 WEEKS | DrugDosageText | CC BY-NC-ND | 34695070 | 20,085,137 | 2021-10-25 |
What was the dosage of drug 'PREDNISONE'? | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | MAINTENANCE THERAPY | DrugDosageText | CC BY-NC-ND | 34695070 | 20,192,442 | 2021-10-25 |
What was the dosage of drug 'TACROLIMUS'? | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | MAINTENANCE THERAPY | DrugDosageText | CC BY-NC-ND | 34695070 | 20,192,442 | 2021-10-25 |
What was the outcome of reaction 'Leiomyosarcoma metastatic'? | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | Recovering | ReactionOutcome | CC BY-NC-ND | 34695070 | 20,099,836 | 2021-10-25 |
What was the outcome of reaction 'Leiomyosarcoma'? | Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.
BACKGROUND Leiomyosarcoma frequently occurs in patients who are on immunosuppressive therapy. It is the second most common sarcoma in this population and is often associated with E... | Recovering | ReactionOutcome | CC BY-NC-ND | 34695070 | 20,217,228 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edema.
In May 2020 and February 2021, capmatinib and tepotinib, respectively were approved by the Food and Drug Administration (FDA) for the treatment of metastatic non-small cell lung carcinoma harboring mesenchymal-epithelial transition (MET) ... | BEVACIZUMAB, CISPLATIN, DOCETAXEL, PEMBROLIZUMAB, PEMETREXED, RAMUCIRUMAB | DrugsGivenReaction | CC BY-NC-ND | 34695875 | 20,563,367 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection.
We rationally designed a bacteriophage cocktail to treat a 56-year-old male liver transplant patient with complex, recurrent prostate and urinary tract infections caused by an extended-spectru... | AZITHROMYCIN, ERTAPENEM SODIUM, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY | 34696479 | 20,112,711 | 2021-10-12 |
What was the administration route of drug 'ERTAPENEM SODIUM'? | Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection.
We rationally designed a bacteriophage cocktail to treat a 56-year-old male liver transplant patient with complex, recurrent prostate and urinary tract infections caused by an extended-spectru... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34696479 | 20,112,711 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Necrosis'. | A neonate with spontaneous arterial limb ischemia and an aneurysm of the oval foramen: a case report.
BACKGROUND
In this case report, we describe a very rare case of severe limb ischemia due to an arterial embolus caused by an aneurysm of the oval foramen in a term-born infant that occurred in the first few hours after... | NITROGLYCERIN | DrugsGivenReaction | CC BY | 34696819 | 20,060,360 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A neonate with spontaneous arterial limb ischemia and an aneurysm of the oval foramen: a case report.
BACKGROUND
In this case report, we describe a very rare case of severe limb ischemia due to an arterial embolus caused by an aneurysm of the oval foramen in a term-born infant that occurred in the first few hours after... | NITROGLYCERIN | DrugsGivenReaction | CC BY | 34696819 | 20,060,360 | 2021-10-25 |
What is the weight of the patient? | A neonate with spontaneous arterial limb ischemia and an aneurysm of the oval foramen: a case report.
BACKGROUND
In this case report, we describe a very rare case of severe limb ischemia due to an arterial embolus caused by an aneurysm of the oval foramen in a term-born infant that occurred in the first few hours after... | 2.980 kg. | Weight | CC BY | 34696819 | 20,060,360 | 2021-10-25 |
What was the administration route of drug 'NITROGLYCERIN'? | A neonate with spontaneous arterial limb ischemia and an aneurysm of the oval foramen: a case report.
BACKGROUND
In this case report, we describe a very rare case of severe limb ischemia due to an arterial embolus caused by an aneurysm of the oval foramen in a term-born infant that occurred in the first few hours after... | Topical | DrugAdministrationRoute | CC BY | 34696819 | 20,060,360 | 2021-10-25 |
What was the dosage of drug 'NITROGLYCERIN'? | A neonate with spontaneous arterial limb ischemia and an aneurysm of the oval foramen: a case report.
BACKGROUND
In this case report, we describe a very rare case of severe limb ischemia due to an arterial embolus caused by an aneurysm of the oval foramen in a term-born infant that occurred in the first few hours after... | SPRAY, | DrugDosageText | CC BY | 34696819 | 20,060,360 | 2021-10-25 |
What was the outcome of reaction 'Necrosis'? | A neonate with spontaneous arterial limb ischemia and an aneurysm of the oval foramen: a case report.
BACKGROUND
In this case report, we describe a very rare case of severe limb ischemia due to an arterial embolus caused by an aneurysm of the oval foramen in a term-born infant that occurred in the first few hours after... | Recovered | ReactionOutcome | CC BY | 34696819 | 20,060,360 | 2021-10-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | ALEMTUZUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, TREOSULFAN, VINCRISTINE | DrugsGivenReaction | CC BY | 34697698 | 20,932,574 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterococcal infection'. | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | ALEMTUZUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, TREOSULFAN, VINCRISTINE | DrugsGivenReaction | CC BY | 34697698 | 20,932,574 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis viral'. | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | ABATACEPT, AZITHROMYCIN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, MELPHALAN, PLERIXAFOR, RITUXIMAB, THIOTEPA, THYMOCYTE IMMUNE GLOBULIN NOS, TREOSULFAN | DrugsGivenReaction | CC BY | 34697698 | 20,916,923 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis'. | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, MELPHALAN, RITUXIMAB, THIOTEPA, THYMOCYTE IMMUNE GLOBULIN NOS, TREOSULFAN | DrugsGivenReaction | CC BY | 34697698 | 20,924,125 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, MELPHALAN, RITUXIMAB, THIOTEPA, THYMOCYTE IMMUNE GLOBULIN NOS, TREOSULFAN | DrugsGivenReaction | CC BY | 34697698 | 20,924,125 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | ALEMTUZUMAB, AZITHROMYCIN, CIPROFLOXACIN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, ITRACONAZOLE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, TREOSULFAN, VINCRISTINE | DrugsGivenReaction | CC BY | 34697698 | 20,850,411 | 2021-10-26 |
What was the dosage of drug 'CYCLOSPORINE'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | D 110 | DrugDosageText | CC BY | 34697698 | 20,579,998 | 2021-10-26 |
What was the dosage of drug 'MELPHALAN'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | 180 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 34697698 | 20,916,923 | 2021-10-26 |
What was the dosage of drug 'PREDNISOLONE'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | UNK, CYCLICAL | DrugDosageText | CC BY | 34697698 | 20,850,411 | 2021-10-26 |
What was the dosage of drug 'THIOTEPA'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | 10 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 34697698 | 20,916,923 | 2021-10-26 |
What was the dosage of drug 'VINCRISTINE'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | UNK, CYCLICAL | DrugDosageText | CC BY | 34697698 | 20,850,411 | 2021-10-26 |
What was the outcome of reaction 'Enterococcal bacteraemia'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | Recovered | ReactionOutcome | CC BY | 34697698 | 20,854,324 | 2021-10-26 |
What was the outcome of reaction 'Epstein-Barr viraemia'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | Recovered | ReactionOutcome | CC BY | 34697698 | 20,854,324 | 2021-10-26 |
What was the outcome of reaction 'Infection'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | Fatal | ReactionOutcome | CC BY | 34697698 | 20,924,125 | 2021-10-26 |
What was the outcome of reaction 'Post transplant lymphoproliferative disorder'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | Recovered | ReactionOutcome | CC BY | 34697698 | 20,854,324 | 2021-10-26 |
What was the outcome of reaction 'Viraemia'? | Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
OBJECTIVE
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a rare disease, caused by CXCR4 gene mutations, which incorporates features of combined immunodeficiency, congenital neutropenia, and a predisposit... | Recovered | ReactionOutcome | CC BY | 34697698 | 20,579,998 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Efficacy of empiric antibiotic management of septic olecranon bursitis without bursal aspiration in emergency department patients.
OBJECTIVE
Many guidelines for septic olecranon bursitis recommend aspiration of the bursa prior to initiation of antimicrobial therapy despite the absence of robust clinical data to support... | DAPTOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34698411 | 20,513,841 | 2021-10-26 |
What was the administration route of drug 'DAPTOMYCIN'? | Efficacy of empiric antibiotic management of septic olecranon bursitis without bursal aspiration in emergency department patients.
OBJECTIVE
Many guidelines for septic olecranon bursitis recommend aspiration of the bursa prior to initiation of antimicrobial therapy despite the absence of robust clinical data to support... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34698411 | 20,513,841 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | CARMUSTINE, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, METHOTREXATE, PREDNISOLONE, RITUXIMAB, TUCIDINOSTAT, VINCRISTINE | DrugsGivenReaction | CC BY | 34698437 | 20,788,372 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | CARMUSTINE, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, METHOTREXATE, PREDNISOLONE, RITUXIMAB, TUCIDINOSTAT, VINCRISTINE | DrugsGivenReaction | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the dosage of drug 'CARMUSTINE'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | UNK (BEAC CONDITIONING REGIMEN) | DrugDosageText | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | UNK, CYCLICAL (RECEIVED FOUR CYCLES OF R-DAEPOCH REGIMEN AND AS A PART OF BEAC CONDITIONING REGIMEN) | DrugDosageText | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the dosage of drug 'DOXORUBICIN'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | UNK, CYCLICAL (RECEIVED FOUR CYCLES OF R-DAEPOCH REGIMEN) | DrugDosageText | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the dosage of drug 'ETOPOSIDE'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | UNK, CYCLICAL, (RECEIVED FOUR CYCLES OF R-DAEPOCH REGIMEN AND AS A PART OF BEAC CONDITIONING REGIMEN | DrugDosageText | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the dosage of drug 'PREDNISOLONE'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | UNK, CYCLICAL (RECEIVED FOUR CYCLES OF R-DAEPOCH REGIMEN) | DrugDosageText | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the dosage of drug 'VINCRISTINE'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | UNK, CYCLICAL (RECEIVED FOUR CYCLES OF R-DAEPOCH REGIMEN) | DrugDosageText | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | Fatal | ReactionOutcome | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the outcome of reaction 'Drug ineffective'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | Fatal | ReactionOutcome | CC BY | 34698437 | 20,788,372 | 2021-11 |
What was the outcome of reaction 'Therapy partial responder'? | Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic st... | Fatal | ReactionOutcome | CC BY | 34698437 | 20,788,372 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study.
Lung lesions of Hodgkin's lymphoma (HL) are rare and difficult to diagnose by nonsurgical biopsy. We herein present the case of a 72-year-old Japanese male who presented with accumulation of lung infiltrates and masses bilaterally on the ... | BRENTUXIMAB VEDOTIN, DACARBAZINE, DOXORUBICIN, VINBLASTINE | DrugsGivenReaction | CC BY | 34698453 | 20,536,137 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study.
Lung lesions of Hodgkin's lymphoma (HL) are rare and difficult to diagnose by nonsurgical biopsy. We herein present the case of a 72-year-old Japanese male who presented with accumulation of lung infiltrates and masses bilaterally on the ... | BRENTUXIMAB VEDOTIN, DACARBAZINE, DOXORUBICIN, VINBLASTINE | DrugsGivenReaction | CC BY | 34698453 | 20,536,137 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cold sweat'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disorientation'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoglycaemia'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,094,011 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insulin autoimmune syndrome'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,111,997 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Presyncope'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,094,011 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
What was the outcome of reaction 'Cold sweat'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
What was the outcome of reaction 'Disorientation'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
What was the outcome of reaction 'Hypoglycaemia'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,094,011 | 2021-10-26 |
What was the outcome of reaction 'Insulin autoimmune syndrome'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,111,997 | 2021-10-26 |
What was the outcome of reaction 'Presyncope'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
What was the outcome of reaction 'Seizure'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,094,011 | 2021-10-26 |
What was the outcome of reaction 'Tremor'? | Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia.
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting fo... | Recovered | ReactionOutcome | CC BY | 34698875 | 20,079,691 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
BACKGROUND
Paraneoplastic neurological syndromes (PNSs) are broad-spectrum disorders that can affect any part of the nervous system varying in core symptoms. Onconeural an... | DROXIDOPA | DrugsGivenReaction | CC BY | 34702214 | 20,153,971 | 2021-10-26 |
What was the administration route of drug 'DROXIDOPA'? | Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
BACKGROUND
Paraneoplastic neurological syndromes (PNSs) are broad-spectrum disorders that can affect any part of the nervous system varying in core symptoms. Onconeural an... | Oral | DrugAdministrationRoute | CC BY | 34702214 | 20,153,971 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cancer fatigue'. | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | ASPARAGINASE, BRENTUXIMAB VEDOTIN, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN, MESNA, METHOTREXATE, PEMBROLIZUMAB, PREDNISONE | DrugsGivenReaction | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34702349 | 20,093,267 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34702349 | 20,093,267 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral motor neuropathy'. | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | ASPARAGINASE, BRENTUXIMAB VEDOTIN, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN, MESNA, METHOTREXATE, PEMBROLIZUMAB, PREDNISONE | DrugsGivenReaction | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral sensory neuropathy'. | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | ASPARAGINASE, BRENTUXIMAB VEDOTIN, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN, MESNA, METHOTREXATE, PEMBROLIZUMAB, PREDNISONE | DrugsGivenReaction | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34702349 | 20,093,267 | 2021-10-26 |
What was the administration route of drug 'ASPARAGINASE'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Intramuscular | DrugAdministrationRoute | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
What was the administration route of drug 'CISPLATIN'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34702349 | 20,269,262 | 2021-10-26 |
What was the administration route of drug 'LEUCOVORIN CALCIUM'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34702349 | 20,244,842 | 2021-10-26 |
What was the administration route of drug 'METHOTREXATE'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Oral | DrugAdministrationRoute | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
What was the dosage of drug 'BRENTUXIMAB'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | 1.8 MILLIGRAM/KILOGRAM EVERY 3 WEEKS | DrugDosageText | CC BY | 34702349 | 20,244,842 | 2021-10-26 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | 15 MILLIGRAM, QID ON DAY 2-4 | DrugDosageText | CC BY | 34702349 | 20,244,842 | 2021-10-26 |
What was the outcome of reaction 'Cancer fatigue'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Not recovered | ReactionOutcome | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
What was the outcome of reaction 'Fatigue'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Not recovered | ReactionOutcome | CC BY | 34702349 | 20,093,267 | 2021-10-26 |
What was the outcome of reaction 'Nausea'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Not recovered | ReactionOutcome | CC BY | 34702349 | 20,093,267 | 2021-10-26 |
What was the outcome of reaction 'Peripheral motor neuropathy'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Recovering | ReactionOutcome | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
What was the outcome of reaction 'Peripheral sensory neuropathy'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Recovering | ReactionOutcome | CC BY | 34702349 | 20,261,738 | 2021-10-26 |
What was the outcome of reaction 'Toxicity to various agents'? | Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
BACKGROUND
Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic lesions in the nasal cavity that re... | Not recovered | ReactionOutcome | CC BY | 34702349 | 20,093,267 | 2021-10-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytosis'. | A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent.
Secondary thrombocytosis, often referred to as a reactive thrombocytosis, is more common than primary thrombocytosis and has many potential etiologies including anemia, infection, inflammation, medications, and post-splenectomy. When consider... | ENOXAPARIN | DrugsGivenReaction | CC BY-NC | 34703325 | 21,015,308 | 2021 |
What was the outcome of reaction 'Thrombocytosis'? | A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent.
Secondary thrombocytosis, often referred to as a reactive thrombocytosis, is more common than primary thrombocytosis and has many potential etiologies including anemia, infection, inflammation, medications, and post-splenectomy. When consider... | Recovered | ReactionOutcome | CC BY-NC | 34703325 | 21,015,308 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | ESOMEPRAZOLE, LANSOPRAZOLE, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 34703419 | 20,983,778 | 2021 |
What was the administration route of drug 'ESOMEPRAZOLE MAGNESIUM'? | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | Oral | DrugAdministrationRoute | CC BY-NC | 34703419 | 20,566,723 | 2021 |
What was the administration route of drug 'LANSOPRAZOLE'? | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | Oral | DrugAdministrationRoute | CC BY-NC | 34703419 | 20,566,723 | 2021 |
What was the administration route of drug 'RABEPRAZOLE'? | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | Oral | DrugAdministrationRoute | CC BY-NC | 34703419 | 20,566,723 | 2021 |
What was the administration route of drug 'VONOPRAZAN'? | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | Oral | DrugAdministrationRoute | CC BY-NC | 34703419 | 20,566,723 | 2021 |
What was the outcome of reaction 'Hypergastrinaemia'? | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | Recovered | ReactionOutcome | CC BY-NC | 34703419 | 20,974,444 | 2021 |
What was the outcome of reaction 'Metaplasia'? | Occurrence of a Duodenal Polypoid Lesion During Long-Term Acid Suppression Therapy and Its Regression After Drug Discontinuation.
Formation of multiple fundic gland polyps or hyperplastic polyps in the gastric mucosa is one of the well-known adverse effects of the long-term acid suppression therapy for peptic ulcer dis... | Recovered | ReactionOutcome | CC BY-NC | 34703419 | 20,974,444 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report.
The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a parado... | METHOTREXATE, SECUKINUMAB | DrugsGivenReaction | CC BY-NC | 34703429 | 19,514,871 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paradoxical drug reaction'. | Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report.
The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a parado... | METHOTREXATE, SECUKINUMAB | DrugsGivenReaction | CC BY-NC | 34703429 | 19,514,871 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vitiligo'. | Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report.
The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a parado... | METHOTREXATE, SECUKINUMAB | DrugsGivenReaction | CC BY-NC | 34703429 | 19,514,871 | 2021 |
What was the dosage of drug 'SECUKINUMAB'? | Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report.
The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a parado... | 300 mg (milligrams). | DrugDosage | CC BY-NC | 34703429 | 19,514,871 | 2021 |
What was the outcome of reaction 'Paradoxical drug reaction'? | Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report.
The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a parado... | Recovering | ReactionOutcome | CC BY-NC | 34703429 | 19,514,871 | 2021 |
What was the outcome of reaction 'Vitiligo'? | Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report.
The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a parado... | Recovering | ReactionOutcome | CC BY-NC | 34703429 | 19,514,871 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time.
The clinicopathological breast cancer subtypes are used in clinical practice to better anticipate biological behaviour and guide systemic treatment strategy. In the adjuvant setting, genomic assay recurrence sco... | CARBOPLATIN, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34703438 | 20,024,539 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematotoxicity'. | Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time.
The clinicopathological breast cancer subtypes are used in clinical practice to better anticipate biological behaviour and guide systemic treatment strategy. In the adjuvant setting, genomic assay recurrence sco... | CARBOPLATIN | DrugsGivenReaction | CC BY-NC | 34703438 | 20,019,040 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time.
The clinicopathological breast cancer subtypes are used in clinical practice to better anticipate biological behaviour and guide systemic treatment strategy. In the adjuvant setting, genomic assay recurrence sco... | CARBOPLATIN, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34703438 | 20,024,539 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time.
The clinicopathological breast cancer subtypes are used in clinical practice to better anticipate biological behaviour and guide systemic treatment strategy. In the adjuvant setting, genomic assay recurrence sco... | CARBOPLATIN, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34703438 | 20,024,539 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time.
The clinicopathological breast cancer subtypes are used in clinical practice to better anticipate biological behaviour and guide systemic treatment strategy. In the adjuvant setting, genomic assay recurrence sco... | CARBOPLATIN | DrugsGivenReaction | CC BY-NC | 34703438 | 20,072,580 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.